Janosch Kratz – “Cannabinoids in chronic pain – How to break a vicious cycle” – PMC19 Lisbon
Janosch Kratz presents “Cannabinoids in Chronic Pain – How to break a vicious cycle”
The use of cannabis in pain is probably the oldest existing condition for the use of Cannabinoids in medicine. As a result of this subject appearing more often in publications; patient statements; newspaper articles etc. people commonly think that Cannabinoids are just another medical Drug to add to the analgesic chart together with other well-known drugs like NSAID’s or Opioids. Working in daily practice with Cannabinoids we learn that there are more medical benefits besides the simple reduction of pain intensity. This presentation explains the multiple ways patients can benefit from cannabis in chronic pain conditions and lightens up limitations of many studies regarding this subject.
Physician and coordinator of Research and Development at Kalapa Clinic — Barcelona
Janosch Kratz is a German born physician who completed his degree in medicine at Universitat Autònoma in Barcelona. Since 2016 he is a full member of the Kalapa Clinic Medical Board looking on a daily base after patients and offering advice on controlled cannabinoid therapies.
As Research & Development Coordinator he is responsible for the development of the Kalapa-Clinic Project and the coordination of medical training & education and creation & dissemination of content in the field of therapeutic cannabis. Today he is living between Berlin and Barcelona completing his specialist training as an GP in Germany and offering advice on Cannabinoid therapies in both countries. In addition, he is currently coordinating the Project “EIMCE – The European Institute for Medical Cannabis Education”, an educational platform which develops CME-certified online courses for healthcare professionals. Over the last years he has been in the Medical Advisory Board of several multinational Companies where he offers consulting for the European market regarding the indications for medical cannabis use, innovative administration routes, quality control and product improvement.
He is working with university research groups, hospitals, health benefit programs, provincial and national committees to create cannabis guidelines, safe THC prescribing practices, clinical trials, patient registries and adverse event monitoring.